布洛芬

  • ibuprofen;Brufen;IBU
布洛芬布洛芬
  1. 和Motrin均是布洛芬的商标

    Motrin and Nuprin are trademarks of brands of ibuprofen tablets . Nuprin

  2. 目的合成布洛芬丁香酚酯并研究其在不同pH水溶液中及血浆、肝匀浆中的水解动力学。

    Objective To synthesize ibuprofen eugenol ester and study its hydrolysis kinetics .

  3. 若干3d过渡金属的布洛芬配合物的合成及其性质的研究

    The synthesis and characterization of the brufen coordination compounds of some 3d transition metals

  4. 布洛芬愈创木酚酯及有关物质的HPLC测定

    Determination of Ibuprofen Guaiacol Ester and Its Related Substances by HPLC

  5. 以HPLC外标法测定精氨酸布洛芬的含量。

    A HPLC method for determination of arginine-ibuprofen is reported .

  6. HPLC同时测定复方布洛芬软胶囊中布洛芬、对乙酰氨基酚的含量

    Determination of ibuprofen and paracetamol in soft capsules by HPLC

  7. HPLC法测定精氨酸布洛芬分散片含量

    HPLC Determination of Arginine Ibuprofen Dispersible Tablets

  8. 手性HPLC法测定布洛芬立体选择性酯化的转化率和对映体过量

    Chiral HPLC Determination of Conversion and Enantiomeric Excess of Enzyme Catalyzed Stereoselective Esterification of Racemic Ibuprofen

  9. HPLC法同时测定布洛伪麻分散片中布洛芬盐酸伪麻黄碱的含量

    HPLC for the simultaneous determination of Ibuprofen and Pseudoephedrine hydrochloride in Ibuprofen and Pseudoephedrine dispersible tablets

  10. NMR研究β-环糊精对布洛芬的手性识别

    NMR Studies of Chiral Discrimination of Ibuprofen Enantiomers in β - Cyclodextrin Inclusion Complexes

  11. 而布洛芬有限地保护糖基化诱导CAT的失活,对SOD的失活无保护作用。

    Ibuprofen showed a limited protection CAT against inactivation by fructose , G6P and glucose but not SOD .

  12. HPLC法测定复方布洛芬干混悬剂中布洛芬及苯巴比妥钠的含量

    Determination of Fenbufen Tablets by HPLC Determination of Ibuprofen and Sodium Phenobarbital in Compound Ibuprofen for Suspension by HPLC

  13. 布洛芬组口服300mg,bid,共观察4周。

    The total course of treatment was 4 weeks .

  14. 合成了两个布洛芬有机胺盐,并用元素分析、红外和X射线粉末衍射对其结构进行了表征,首次报道了布洛芬乙胺盐的晶体结构。

    This paper describes the syntheses and structural characterization of two amine salts of ibupro ˉ fenusing elemental analyses , IR and X_ray powder diffrac ˉ tion techniques .

  15. 结果:形成复合物后布洛芬在水中的溶解度明显增加,其溶液浓度可达100mg/mL,最稳定pH范围是6.0~7.0。

    Results : The solubility of ibuprofen in water was increased after the formation of the complex , and an ibuprofen solution ( 100 mg / mL ) was obtained .

  16. 应用毛细管区带电泳法测定复方布洛芬片剂的含量,所得结果与HPLC法一致。

    The proposed method has been applied for the analysis of compound ibuprofen tablets , and the analytical results are in good agreement with those obtained by HPLC method .

  17. 目的测定布洛芬丁香酚酯(ibuprofeneugenolester,IEE)微乳中布洛芬丁香酚酯及有关物质的含量。

    Objective To determine the contents and the related substances of ibuprofen eugenol ester in microemulsion .

  18. 虽然许多体内外试验结果都表明,S(+)-布洛芬作为优对映体在抑制前列腺素生成上优于R(-)-布洛芬,然而,市售的产品中仍多数为消旋体形式。

    Although the S ( + ) - enantiomer of ibuprofen is the eutomer with respect to inhibition of prostaglandin formation , the marketed products containing ibuprofen are almost all supplied as the racemate .

  19. 方法:8名健康男性志愿者单剂量随机交叉po400mg布洛芬后,采用HPLC测定血浆药物浓度。

    METHODS : The drug concentration in plasma was assayed by HPLC method after administration of a single oral dose of 400 mg ibuprofen to each of 8 healthy male volunteers .

  20. 结论布洛芬聚乳酸微球能够有效的治疗CVS,其机制可能与抑制血管壁的炎症反应有关。

    Conclusion Ibuprofen polylactide microspheres can treat CVS effectively . Its possible mechanisms may relate to the inhibition of inflammation reaction .

  21. 目的探讨布洛芬川芎嗪酯(ITE)的抗炎机制。

    Objective To elucidate the anti-inflammation mechanism of ibuprofen tetramethylpyrazine ester ( ITE ) .

  22. 结果:布洛芬不溶性骨架缓释片的药物释放规律符合Higuchi方程;

    Results : The release behavior of the tablets follows the Higuchi equation ;

  23. 以硬脂精为载体材料,采用熔融-冷却法制备包载布洛芬的固体脂微颗粒(SLM),研究了不同稳定剂对SLM载药体系的稳定效果。

    The emulsion-congealing method was adopted to prepare ibuprofen-loaded solid lipid microparticles ( SLM ) with tristearin as the carrier .

  24. 目的建立一种快速、专属的HPLCUV法用于测定比格犬血浆中右旋布洛芬的浓度,应用本法对右旋布洛芬缓释胶囊在比格犬体内的药物动力学行为进行研究。

    Objective To develop a rapid and specific HPLC-UV method for the determination of dexibuprofen in Beagle dog plasma , and use it to investigate the pharmacokinetics of dexibuprofen in Beagle dog plasma .

  25. 布洛芬组32例,给予布洛芬300mg,po,bid,疗程4wk。

    Ibuprofen group of thirty-two patients received ibuprofen 300 mg , po , bid , for 4 wk .

  26. 此外,以该药物端基非离子表面活性剂胶束为模板通过一步法合成了介孔SiO2-布洛芬药物释放体系。

    Moreover , a drug controlled-release system of mesoporous silica / ibuprofen was synthesized under one step method with the ibuprofen containing nonionic surfactant as the template .

  27. 目的研究布洛芬(ibuprofen)的热分解行为,推导出其最可能的热分解反应机制,并求出相关的动力学参数。

    OBJECTIVE To determine thermal decomposing behavior of ibuprofen , speculate the probable mechanism of thermal decomposing reaction and calculate the kinetic parameters .

  28. 同一取代度的HC对布洛芬的释放量随着载药量的增加而增加,随着成片压力的增加而下降。

    While at the same DS level , the releasing rate increased with the increase of drug loading , decreased with the increase of compression stress .

  29. 研究羟丙甲纤维素(HPM)理化性质对布洛芬-HPMC凝胶骨架片释放度的影响。

    PURPOSE To study the effect of physicochemical properties of hydroxypropyl methylcellulose ( HPMC ) on dissolution rate of ibuprofen-HPMC matrix tablets .

  30. 在试验的五种布洛芬消旋酯中,水解甲酯和异丙酯生成s(+)-布洛芬ee可达97%,乙酯为93%以上;

    Among the five chosen substrate , asymmetric hydrolysis of methyl ester or isopropyl ester formed S ( + ) - ibuprofen of 97 % ee .